Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Durham

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
American Journal of Ophthalmology|February 10, 2023
Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 YearsJacque L Duncan, Peiyao Cheng, Maureen G Maguire, et al.
Neuron|March 16, 2023
Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1Stephanie L Coffin, Mark A Durham, Larissa Nitschke, et al.
Elife|March 12, 2020
Losing Dnmt3a dependent methylation in inhibitory neurons impairs neural function by a mechanism impacting Rett syndromeLaura A Lavery, Kerstin Ure, Ying-Wooi Wan, et al.
Preventing Chronic Disease|February 24, 2017
Cost-Effectiveness Analysis of Four Simulated Colorectal Cancer Screening Interventions, North CarolinaKristen Hassmiller Lich, David A Cornejo, Maria E Mayorga, et al.
Neuron|December 28, 2022
Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1Stephanie L Coffin, Mark A Durham, Larissa Nitschke, et al.
American Journal of Medical Genetics. Part A|July 31, 2021
Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A)Alessandro Iannaccone, Carmen C Brewer, Peiyao Cheng, et al.
Biomedicines|July 27, 2024
Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASDCraig A Erickson, Laura Perez-Cano, Ernest V Pedapati, et al.
Molecular Nutrition & Food Research|May 29, 2016
Obese ZDF rats fermented resistant starch with effects on gut microbiota but no reduction in abdominal fatFelicia Goldsmith, Justin Guice, Ryan Page, et al.
Human Mutation|March 10, 2022
Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A studyRobert B Hufnagel, Wendi Liang, Jacque L Duncan, et al.
Veterinary Pathology|September 24, 2010
Classification of canine malignant lymphomas according to the World Health Organization criteriaV E Valli, M San Myint, A Barthel, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
American Journal of Ophthalmology|February 10, 2023
Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 YearsJacque L Duncan, Peiyao Cheng, Maureen G Maguire, et al.
Neuron|March 16, 2023
Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1Stephanie L Coffin, Mark A Durham, Larissa Nitschke, et al.
Elife|March 12, 2020
Losing Dnmt3a dependent methylation in inhibitory neurons impairs neural function by a mechanism impacting Rett syndromeLaura A Lavery, Kerstin Ure, Ying-Wooi Wan, et al.
Preventing Chronic Disease|February 24, 2017
Cost-Effectiveness Analysis of Four Simulated Colorectal Cancer Screening Interventions, North CarolinaKristen Hassmiller Lich, David A Cornejo, Maria E Mayorga, et al.
Neuron|December 28, 2022
Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1Stephanie L Coffin, Mark A Durham, Larissa Nitschke, et al.
American Journal of Medical Genetics. Part A|July 31, 2021
Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A)Alessandro Iannaccone, Carmen C Brewer, Peiyao Cheng, et al.
Biomedicines|July 27, 2024
Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASDCraig A Erickson, Laura Perez-Cano, Ernest V Pedapati, et al.
Molecular Nutrition & Food Research|May 29, 2016
Obese ZDF rats fermented resistant starch with effects on gut microbiota but no reduction in abdominal fatFelicia Goldsmith, Justin Guice, Ryan Page, et al.
Human Mutation|March 10, 2022
Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A studyRobert B Hufnagel, Wendi Liang, Jacque L Duncan, et al.
Veterinary Pathology|September 24, 2010
Classification of canine malignant lymphomas according to the World Health Organization criteriaV E Valli, M San Myint, A Barthel, et al.
Pageof 21